全文获取类型
收费全文 | 6782篇 |
免费 | 553篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 358篇 |
妇产科学 | 245篇 |
基础医学 | 846篇 |
口腔科学 | 76篇 |
临床医学 | 884篇 |
内科学 | 1538篇 |
皮肤病学 | 63篇 |
神经病学 | 668篇 |
特种医学 | 234篇 |
外国民族医学 | 1篇 |
外科学 | 861篇 |
综合类 | 113篇 |
一般理论 | 11篇 |
预防医学 | 587篇 |
眼科学 | 52篇 |
药学 | 379篇 |
中国医学 | 5篇 |
肿瘤学 | 362篇 |
出版年
2021年 | 120篇 |
2020年 | 66篇 |
2019年 | 90篇 |
2018年 | 117篇 |
2017年 | 79篇 |
2016年 | 71篇 |
2015年 | 108篇 |
2014年 | 162篇 |
2013年 | 225篇 |
2012年 | 306篇 |
2011年 | 323篇 |
2010年 | 187篇 |
2009年 | 170篇 |
2008年 | 292篇 |
2007年 | 318篇 |
2006年 | 275篇 |
2005年 | 301篇 |
2004年 | 327篇 |
2003年 | 269篇 |
2002年 | 286篇 |
2001年 | 227篇 |
2000年 | 264篇 |
1999年 | 230篇 |
1998年 | 94篇 |
1997年 | 70篇 |
1996年 | 76篇 |
1995年 | 52篇 |
1994年 | 76篇 |
1993年 | 59篇 |
1992年 | 147篇 |
1991年 | 164篇 |
1990年 | 155篇 |
1989年 | 151篇 |
1988年 | 137篇 |
1987年 | 154篇 |
1986年 | 94篇 |
1985年 | 131篇 |
1984年 | 90篇 |
1983年 | 77篇 |
1982年 | 46篇 |
1981年 | 47篇 |
1980年 | 31篇 |
1979年 | 76篇 |
1978年 | 61篇 |
1977年 | 35篇 |
1976年 | 54篇 |
1974年 | 51篇 |
1973年 | 57篇 |
1972年 | 32篇 |
1971年 | 34篇 |
排序方式: 共有7347条查询结果,搜索用时 375 毫秒
1.
2.
CDC's consensus set of health status indicators: monitoring and prioritization by state health departments. 下载免费PDF全文
A survey assessed the extent to which state health departments monitor and prioritize the Centers for Disease Control and Prevention's consensus set of health status indicators. A response rate of 100% was obtained. Although mortality indicators are often monitored, only 75.5% of the states monitor work-related injury deaths. Most states monitor the incidence of acquired immunodeficiency syndrome, measles, tuberculosis, and syphilis. Low birthweight, births to adolescents, and lack of prenatal care are monitored in nearly all states and are considered high-priority problems. Only 46.9% of states are monitoring poor air quality, and only 58.8% are monitoring childhood poverty. Survey results suggest a need for standardized assessment of indicators for policy development and program planning. 相似文献
3.
4.
5.
6.
In preventive medicine and occupational health, decision-makers face uncertainty, divergent opinions, and varying needs. In the Swiss aluminum industry, screening for industrial fluorosis illustrates how decision analysis and cost-effectiveness analysis can provide rational and explicit models of decision-making in such contexts. Data on fluoride-exposed potroom workers are used to compare the cost-effectiveness of two strategies: mass screening of fluorosis versus individual detection of the disease on the basis of the worker's symptoms. A decision-analysis and a sensitivity analysis are performed to assess the impact of the screening program for different levels of expected prevalence of the disease. The optimal decision, in economic terms, is the one that minimizes the pension and screening-related costs and maximizes the number of years of full working capacity. Swiss data suggest that a diagnosis of clinical fluorosis is unlikely before 10 years of exposure to fluoride. Between 10 and 30 years of exposure to fluoride, mass screening may be more cost-effective than individual detection of the disease, even when the expected prevalence of the disease in a given industrial setting is less than 10%. 相似文献
7.
Philip S Wells Josdalyne L Anderson Marc A Rodger Nancy Carson Rebecca L Grimwood Steve P Doucette 《Blood coagulation & fibrinolysis》2006,17(7):533-538
The substitution of leucine for valine at amino acid position 34 of the factor XIII gene is commonly referred to as FXIII Val34Leu polymorphism. The homozygous leucine/leucine genotype has been reported to confer protection against venous thromboembolism, but previous studies have not evaluated a population limited to those with idiopathic venous thromboembolism. The primary objective of the study was to determine whether the FXIII Val34Leu polymorphism is independently associated with the occurrence of idiopathic venous thromboembolism. We prospectively enrolled consecutive patients with at least one objectively confirmed idiopathic venous thromboembolism. Friends of cases were recruited as controls and matched to cases by sex, ethnicity, and age. All participants were tested for the FXIII Val34Leu polymorphism in addition to several well-known thrombophilias. Data from 309 cases and 306 controls were analyzed. The FXIII leucine/leucine genotype was present in 4.9% of cases and 6.5% of controls. An adjusted odds ratio of 0.59 (95% confidence interval, 0.25-1.38) was found for the recessive model and 0.69 (95% confidence interval, 0.46-1.02) for the dominant model. Our results do not support an independent association of the FXIII Val34Leu polymorphism with idiopathic venous thromboembolism in our Caucasian Canadian study population. 相似文献
8.
Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy 总被引:5,自引:3,他引:2 下载免费PDF全文
J M Moutquin P R Garner R F Burrows E Rey M E Helewa I R Lange S W Rabkin 《Canadian Medical Association journal》1997,157(7):907-919
OBJECTIVE: To provide Canadian physicians with comprehensive, evidence-based guidelines for the nonpharmacologic management and prevention of gestational hypertension and pre-existing hypertension during pregnancy. OPTIONS: Lifestyle modifications, dietary or nutrient interventions, plasma volume expansion and use of prostaglandin precursors or inhibitors. OUTCOMES: In gestational hypertension, prevention of complications and death related to either its occurrence (primary or secondary prevention) or its severity (tertiary prevention). In pre-existing hypertension, prevention of superimposed gestational hypertension and intrauterine growth retardation. EVIDENCE: Articles retrieved from the pregnancy and childbirth module of the Cochrane Database of Systematic Reviews; pertinent articles published from 1966 to 1996, retrieved through a MEDLINE search; and review of original randomized trials from 1942 to 1996. If evidence was unavailable, consensus was reached by the members of the consensus panel set up by the Canadian Hypertension Society. VALUES: High priority was given to prevention of adverse maternal and neonatal outcomes in pregnancies with established hypertension and in those at high risk of gestational hypertension through the provision of effective nonpharmacologic management. BENEFITS, HARMS AND COSTS: Reduction in rate of long-term hospital admissions among women with gestational hypertension, with establishment of safe home-care blood pressure monitoring and appropriate rest. Targeting prophylactic interventions in selected high-risk groups may avoid ineffective use in the general population. Cost was not considered. RECOMMENDATION: Nonpharmacologic management should be considered for pregnant women with a systolic blood pressure of 140-150 mm Hg or a diastolic pressure of 90-99 mm Hg, or both, measured in a clinical setting. A short-term hospital stay may be required for diagnosis and for ruling out severe gestational hypertension (preeclampsia). In the latter case, the only effective treatment is delivery. Palliative management, dependent on blood pressure, gestational age and presence of associated maternal and fetal risk factors, includes close supervision, limitation of activities and some bed rest. A normal diet without salt restriction is advised. Promising preventive interventions that may reduce the incidence of gestational hypertension, especially with proteinuria, include calcium supplementation (2 g/d), fish oil supplementation and low-dose acetylsalicylic acid therapy, particularly in women at high risk for early-onset gestational hypertension. Pre-existing hypertension should be managed the same way as before pregnancy. However, additional concerns are the effects on fetal well-being and the worsening of hypertension during the second half of pregnancy. There is, as yet, no treatment that will prevent exacerbation of the condition. VALIDATION: The guidelines share the principles in consensus reports from the US and Australia on the nonpharmacologic management of hypertension in pregnancy. 相似文献
9.
10.
Vascular malformations of the spinal cord: intrathecal perimedullary arteriovenous fistulas fed by medullary arteries 总被引:3,自引:0,他引:3
We studied eleven patients with intrathecal extramedullary arteriovenous fistulas identified by selective angiography and myelography. The fistulas were located on the surface of the cord, fed by medullary arteries. Angiography distinguished three separate types that gave identical clinical disorders. Therapeutic results of surgery and embolization allowed specific indications to be defined for treatment of each type of fistula. 相似文献